Altered endosome biogenesis in prostate cancer has biomarker potential.
Altered endosome biogenesis in prostate cancer has biomarker potential.
复制标题
前列腺癌中内体生物发生的改变具有生物标志物潜力。
DOI:
10.1158/1541-7786.mcr-14-0074
复制
发表时间:
2014-12
期刊:
影响因子:
--
通讯作者:
Brooks DA
中科院分区:
文献类型:
--
作者:
Johnson IR;Parkinson-Lawrence EJ;Shandala T;Weigert R;Butler LM;Brooks DA
Prostate cancer is the second most common form of cancer in males, affecting one in eight men by the time they reach the age of 70. Current diagnostic tests for prostate cancer have significant problems with both false negatives and false positives, necessitating the search for new molecular markers. A recent investigation of endosomal and lysosomal proteins revealed that the critical process of endosomal biogenesis might be altered in prostate cancer. Here, a panel of endosomal markers was evaluated in prostate cancer and non-malignant cells and a significant increase in gene and protein expression was found for early, but not late endosomal proteins. There was also a differential distribution of early endosomes, and altered endosomal traffic and signalling of the transferrin receptors (TFRC and TFR2) in prostate cancer cells. These findings support the concept that endosome biogenesis and function is altered in prostate cancer. Microarray analysis of a clinical cohort confirmed the altered endosomal gene expression observed in cultured prostate cancer cells. Furthermore, in prostate cancer patient tissue specimens, the early endosomal marker and adaptor protein APPL1 showed consistently altered basement membrane histology in the vicinity of tumours and concentrated staining within tumour masses. These novel observations on altered early endosome biogenesis provide a new avenue for prostate cancer biomarker investigation and suggest new methods for the early diagnosis and accurate prognosis of prostate cancer.